60 mn Americans now eligible for Pfizer booster shots, Biden says

COVID-19 booster
Credit: Unsplash/CC0 Public Domain

Some 60 million people in the United States are now eligible for a Pfizer booster shot against COVID-19, President Joe Biden said on Friday as a regulatory marathon laying bare divisions within the scientific community on the issue came to a close.

In the end, US health authorities have recommended boosters for three categories of people: those 65 and older, those 18-64 with an underlying medical condition such as diabetes or obesity, and those who are especially exposed to the virus because of their work or where they live.

The at-risk group is large and includes teachers, grocery store employees, health care workers, prisoners and people living in homeless shelters.

A total of 20 million people got their second Pfizer shot long enough ago—at least six months—to qualify now for a , Biden said.

“Go get the booster,” he said in remarks at the White House.

“I’ll be getting my booster shot,” the 78-year-old president added, “as soon as I can.”

Biden said people who have received Moderna or Johnson & Johnson vaccinations could get booster shots once studies have been completed and he expected that all Americans would be eligible “in the near term.”

Rochelle Walensky, director of the Centers for Disease Control and Prevention (CDC), said Friday that data on Moderna and Johnson & Johnson booster shots would be evaluated “in the coming weeks.”

Some immunocompromised people in the United States have been eligible to receive a third dose of the Pfizer or Moderna vaccine since early August.

Biden had wanted to launch a mass campaign of Pfizer and Moderna booster shots this week for all Americans.

But the move was put on hold by the US health authorities. Moderna did not submit the necessary data in time and experts were divided about what to do regarding Pfizer.

The CDC on Friday overruled its own panel of health experts to back Pfizer booster shots for individuals at high risk of exposure to COVID-19 because of their jobs.

‘The greatest good’

Walensky said the agency had to act on “complex, often imperfect data” for the greater good of public health.

“In a pandemic, even with uncertainty, we must take actions that we anticipate will do the greatest good,” she said.

Speaking at a briefing on Friday, the CDC director said “our healthcare systems are once again at maximum capacity in parts of the country.

“Our teachers are facing uncertainty as they walk into the classroom, and I must do what I can to preserve the health across our nation,” she said.

The CDC backed the expert panel’s recommendation of booster shots for over-65s and some with underlying medical conditions.

The decision came after the US Food and Drug Administration (FDA) approved Pfizer booster shots for a broader swathe of the American public.

A day before the CDC recommendation, its expert committee had voted against offering booster shots to workers in the higher risk category, adding to confusion around the campaign.

The hours-long debate left several experts torn, as the scientific community has so far failed to reach consensus on whether a coronavirus vaccine booster shot is necessary at this time.

Some experts have concerns about the lack of data on the efficacy and safety of adding another shot to the Pfizer vaccine regimen.

The original two doses are still proving successful at keeping the vast majority of their recipients out of the hospital with coronavirus, they say.

But data does suggest that the vaccine’s efficacy against infection does significantly decline in older people over time.

© 2021 AFP

Citation: 60 mn Americans now eligible for Pfizer booster shots, Biden says (2021, September 25) retrieved 2 October 2021 from https://medicalxpress.com/news/2021-09-mn-americans-eligible-pfizer-booster.html

This document is subject to copyright. Apart from any fair dealing for the purpose of private study or research, no part may be reproduced without the written permission. The content is provided for information purposes only.

Note: This article have been indexed to our site. We do not claim ownership or copyright of any of the content above. To see the article at original source Click Here

Related Posts
Bright Health's financial troubles spread to Tennessee thumbnail

Bright Health’s financial troubles spread to Tennessee

Skip to main content Bright Health Group can add Tennessee to the growing list of states concerned about its ability to meet its financial obligations. Tennessee regulators placed the struggling health insurance company under supervision in November, according to Tennessee Department of Commerce and Insurance filings. Bright Health has been prohibited from spending more than
Read More
Experts Warn of the Extreme Public Health Threats From Heat thumbnail

Experts Warn of the Extreme Public Health Threats From Heat

Special Reports > Features — Cities and individuals can prevent heat-related illnesses, they say by Sophie Putka, Enterprise & Investigative Writer, MedPage Today August 11, 2023 As record-breaking heat waves from climate change transform weather patterns and ecosystems, healthcare will also need to shift to contend with these new realities. During SciLine's "Extreme Heat Update"
Read More
Time can't be played back, this is why face-to-face school is important thumbnail

Time can't be played back, this is why face-to-face school is important

PENURUNAN jumlah kasus positif Covid-19 di Indonesia membuat pemerintah membuka kembali beberapa sekolah. Pembelajaran Tatap Muka (PTM) pun bisa dilakukan di beberapa wilayah, tentunya dengan protokol kesehatan yang ketat. Tapi, masalah timbul setelah beberapa sekolah melaporkan ada sejumlah siswa yang terpapar Covid-19. Sejumlah klaster sekolah bermunculan imbas dari PTM yang kembali dibuka. Pakar Epidemiologi Universitas…
Read More
Listen: Mifepristone Remains Available for Now. What Happens Next? thumbnail

Listen: Mifepristone Remains Available for Now. What Happens Next?

The Supreme Court has ruled that the abortion pill mifepristone should remain widely available for now, a decision that maintains access to the drug while the lower courts consider the issue. Julie Rovner, KFF Health News’ chief Washington correspondent, appeared on NPR’s “Weekend All Things Considered” to explain the complicated, even contradictory court decisions surrounding
Read More
Index Of News
Consider making some contribution to keep us going. We are donation based team who works to bring the best content to the readers. Every donation matters.
Donate Now

Subscription Form

Liking our Index Of News so far? Would you like to subscribe to receive news updates daily?